A 3D‐Printed Compact Multi‐Nozzle Microfluidic Device for Scalable Microencapsulation of Pluripotent Stem Cells
Advanced Healthcare Materials · 2026-05 · 15 (20)
DOI: 10.1002/adhm.202600018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 21.03.2026. Verfasst von Quoc Huynh Nguyen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiological and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Pluripotent Stem Cells, Printing, Three-Dimensional, Lab-On-A-Chip Devices, Cell Encapsulation. Die Arbeit nennt 48 Literaturangaben. Gefördert von: ARPA-H, NIH HHS, Mayo Clinic Foundation.
Abstract (Originalsprache)
Encapsulation of human pluripotent stem cells (hPSC) has high relevance for biomedical applications ranging from tissue engineering to drug screening and cellular therapies. Microcapsules serve a multitude of purposes—from promoting hPSC organization into spheroids to enabling scalable differentiation in vitro and providing immunoisolation in vivo. While multiple encapsulation strategies have been reported, there is typically a tradeoff between the structural complexity of capsules and throughput of their generation. Our paper describes a novel 3D printed microfluidic encapsulation device for fabricating structurally complex microcapsules with a hydrogel shell and aqueous core at rates of up to 1825 Hz. The use of 3D printing allowed to dramatically decrease device footprint when compared to standard soft lithography‐based microfluidic encapsulation devices. Leveraging decreased footprint and the ability to arrange fluidic networks in a 3D space, we fabricated a 10‐nozzle microencapsulation device that generated microcapsules at a rate 10‐times that of the single‐nozzle device. The novel microfluidic device was used to encapsulate hPSCs, human embryonic stem cells (hESCs), and induced pluripotent stem cells (iPSCs). Hydrogel microcapsules with aqueous core promoted hPSCs aggregation into spheroids or embryoid bodies, which maintained high levels of pluripotency. Our technology enables safe and effective encapsulation of hPSCs on a scale (billions of cells) required to treat patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiological and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota, USA.
- Case Western Reserve University and Department of Chemical and Biomolecular Engineering, Cleveland, Ohio, USA.
- Department of Biofibers and Biomaterials Science, Kyungpook National University, Daegu, Republic of Korea.
ORCID-Profile: Quoc Huynh Nguyen, Alexander Revzin
Förderung
- ARPA-H
- NIH HHS
- Mayo Clinic Foundation
- National Science Foundation
Zitieren
APA
Nguyen, Q. H., Nguyen, K., Che, Q. T., Choi, D., Jaberi, S. H., Gwon, K., Baskaran, H., Stybayeva, G., Peterson, Q., & Revzin, A. (2026). A 3D‐Printed Compact Multi‐Nozzle Microfluidic Device for Scalable Microencapsulation of Pluripotent Stem Cells. Advanced Healthcare Materials, 15(20). https://doi.org/10.1002/adhm.202600018
Vancouver
Nguyen QH, Nguyen K, Che QT, Choi D, Jaberi SH, Gwon K, et al. A 3D‐Printed Compact Multi‐Nozzle Microfluidic Device for Scalable Microencapsulation of Pluripotent Stem Cells. Advanced Healthcare Materials. 2026;15(20). doi:10.1002/adhm.202600018
BibTeX
@article{Nguyen2026,
author = {Nguyen, Quoc Huynh and Nguyen, Kianna and Che, Quang Tuan and Choi, Daheui and Jaberi, Seyed Hassan and Gwon, Kihak and Baskaran, Harihara and Stybayeva, Gulnaz and Peterson, Quinn and Revzin, Alexander},
title = {A 3D‐Printed Compact Multi‐Nozzle Microfluidic Device for Scalable Microencapsulation of Pluripotent Stem Cells},
journal = {Advanced Healthcare Materials},
year = {2026},
volume = {15},
number = {20},
doi = {10.1002/adhm.202600018}
}
EUVIMED